Myelin Detection Using Rapid Quantitative MR Imaging Correlated to Macroscopically Registered Luxol Fast Blue–Stained Brain Specimens

References

1. 1.↵
   2. Miller DH,
   3. Barkhof F,
   4. Frank JA, et al

   . Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676–95 doi:10.1093/brain/awf177 pmid:12135961

   Abstract/FREE Full Text
2. 2.↵
   2. Bakshi R,
   3. Thompson AJ,
   4. Rocca MA, et al

   . MRI in multiple sclerosis: current status and future prospects. Lancet Neurol 2008;7:615–25 doi:10.1016/S1474-4422(08)70137-6 pmid:18565455

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Ihara M,
   3. Polvikoski TM,
   4. Hall R, et al

   . Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol 2010;119:579–89 doi:10.1007/s00401-009-0635-8 pmid:20091409

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Back SA,
   3. Riddle A,
   4. McClure MM

   . Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke 2007;38:724–30 doi:10.1161/01.STR.0000254729.27386.05 pmid:17261726

   Abstract/FREE Full Text
5. 5.↵
   2. Croteau-Chonka EC,
   3. Dean DC 3rd.,
   4. Remer J, et al

   . Examining the relationships between cortical maturation and white matter myelination throughout early childhood. Neuroimage 2016;125:413–21 doi:10.1016/j.neuroimage.2015.10.038 pmid:26499814

   CrossRefPubMed
6. 6.↵
   2. MacKay A,
   3. Laule C,
   4. Vavasour I., et al

   . Insights into brain microstructure from the T2 distribution. Magn Reson Imag 2006;24:515–25 doi:10.1016/j.mri.2005.12.037 pmid:16677958

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Oh J,
   3. Han ET,
   4. Lee MC, et al

   . Multislice brain myelin water fractions at 3T in multiple sclerosis. J Neuroimaging 2007;17:156–63 doi:10.1111/j.1552-6569.2007.00098.x pmid:17441837

   CrossRefPubMed
8. 8.↵
   2. Deoni SC,
   3. Rutt BK,
   4. Arun T, et al

   . Gleaning multicomponent T1 and T2 information from steady-state imaging data. Magn Reson Med 2008;60:1372–87 doi:10.1002/mrm.21704 pmid:19025904

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Levesque IR,
   3. Pike GB

   . Characterizing healthy and diseased white matter using quantitative magnetization transfer and multicomponent T(2) relaxometry: A unified view via a four-pool model. Magn Reson Med 2009;62:1487–96 doi:10.1002/mrm.22131 pmid:19859946

   CrossRefPubMed
10. 10.↵
    2. Alonso-Ortiz E,
    3. Levesque IR,
    4. Pike GB

    . MRI-based myelin water imaging: a technical review. Magn Reson Med 2015;73:70–81 doi:10.1002/mrm.25198 pmid:24604728

    CrossRefPubMed
11. 11.↵
    2. Warntjes M,
    3. Engström M,
    4. Tisell A, et al

    . Modelling the presence of myelin and edema in the brain based on multi-parametric quantitative MRI. Front Neurol 2016;7:16 doi:10.3389/fneur.2016 pmid:26925030

    CrossRefPubMed
12. 12.↵
    2. Warntjes JBM,
    3. Dahlqvist O,
    4. West J, et al

    . Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magn Reson Med 2008;60:320–29 doi:10.1002/mrm.21635 pmid:18666127

    CrossRefPubMed
13. 13.↵
    2. Tashiro K,
    3. Shiotani S,
    4. Kobayashi T, et al

    . Cerebral relaxation times from postmortem MR imaging of adults. Magn Reson Med Sci 2015;14:51–56 doi:10.2463/mrms.2013-0126 pmid:25500777

    CrossRefPubMed
14. 14.↵
    2. Zech WD,
    3. Hottinger AL,
    4. Schwendener N, et al

    . Post-mortem 1.5T MR quantification of regular anatomical brain structures. Int J Legal Med 2016;130:1071–80 doi:10.1007/s00414-016-1318-3 pmid:26872469

    CrossRefPubMed
15. 15.↵
    2. Engström M,
    3. Warntjes JB,
    4. Tisell A, et al

    . Multi-parametric representation of voxel-based quantitative magnetic resonance imaging. PLoS One 2014;9:e111688 doi:10.1371/journal.pone.0111688 pmid:25393722

    CrossRefPubMed
16. 16.↵
    2. Hausmann R,
    3. Vogel C,
    4. Seidl S, et al

    . Value of morphological parameters for grading of brain swelling. Int J Legal Med 2006;120:219–25 doi:10.1007/s00414-005-0021-6 pmid:16059709

    CrossRefPubMed
17. 17.↵
    2. Dettmeyer RB

    . Forensic Neuropathology: Forensic Histopathology. Berlin: Springer; 2011:413–438
18. 18.↵
    1. Oehmichen M,
    2. Auer RN,
    3. König HG

    2. Oehmichen M,
    3. Auer RN,
    4. König HG

    . Cell and tissue reactions. In: Oehmichen M, Auer RN, König HG. Forensic Neuropathology and Associated Neurology. Berlin: Springer; 2006:42–76
19. 19.↵
    2. Warntjes JB,
    3. Engström M,
    4. Tisell A, et al

    . Brain characterization using normalized quantitative magnetic resonance imaging. PLoS One 2013;8:e70864 doi:10.1371/journal.pone.0070864 pmid:23940653

    CrossRefPubMed
20. 20.↵
    2. Birkl C,
    3. Langkammer C,
    4. Haybaeck J, et al

    . Temperature dependency of T1 relaxation time in unfixed and fixed human brain tissue. NMR Biomed 2016;29:458–65
21. 21.↵
    2. Moore GR,
    3. Leung E,
    4. MacKay AL, et al

    . A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain. Neurology 2000;55:1506–10 doi:10.1212/WNL.55.10.1506 pmid:11094105

    Abstract/FREE Full Text
22. 22.↵
    2. Bronge L,
    3. Bogdanovic N,
    4. Wahlund LO

    . Postmortem MRI and histopathology of white matter changes in Alzheimer brains: a quantitative, comparative study. Dement Geriatr Cogn Disord 2002;13:205–12 doi:10.1159/000057698 pmid:12006730

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Granberg T,
    3. Uppman M,
    4. Hashim F, et al

    . Clinical feasibility of synthetic MRI in multiple sclerosis: a diagnostic and volumetric validation study. AJNR Am J Neuroradiol 2016;37:1023–29 doi:10.3174/ajnr.A4665 pmid:26797137

    Abstract/FREE Full Text
24. 24.↵
    2. Hagiwara A,
    3. Hori M,
    4. Yokoyama K, et al

    . Utility of a multiparametric quantitative MRI model that assesses myelin and edema for evaluating plaques, periplaque white matter, and normal-appearing white matter in patients with multiple sclerosis: a feasibility study. AJNR Am J Neuroradiol 2017;38:237–42 doi:10.3174/ajnr.A4977 pmid:27789453

    Abstract/FREE Full Text
25. 25.↵
    2. Laule C,
    3. Leung E,
    4. Lis DK, et al

    . Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult Scler 2006;12:747–53 doi:10.1177/1352458506070928 pmid:17263002

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Laule C,
    3. Vavasour IM,
    4. Leung E, et al

    . Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology. Mult Scler 2011;17:144–50 doi:10.1177/1352458510384008 pmid:20965961

    CrossRefPubMed
27. 27.↵
    2. Neema M,
    3. Stankiewicz J,
    4. Arora A, et al

    . T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging 2007;17:16S–21S doi:10.1111/j.1552-6569.2007.00131.x pmid:17425729

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Larsson HB,
    3. Frederiksen J,
    4. Petersen J, et al

    . Assessment of demyelination, edema and gliosis by in-vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis. Magn Reson Med 1989;11:337–48 pmid:2779421

    CrossRefPubMed